Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice
出版年份 2019 全文链接
标题
Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice
作者
关键词
-
出版物
MOLECULAR NEUROBIOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-12-14
DOI
10.1007/s12035-019-01849-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
- (2019) Amanda Cano et al. JOURNAL OF CONTROLLED RELEASE
- Proteomic approaches for novel systemic lupus erythematosus (SLE) drug discovery
- (2018) Yaxi Li et al. Expert Opinion on Drug Discovery
- Endoplasmic reticulum chaperone GRP78 regulates macrophage function and insulin resistance in diet-induced obesity
- (2018) Jong Hun Kim et al. FASEB JOURNAL
- The critical role of epigallocatechin gallate in regulating mitochondrial metabolism
- (2018) Weimei Shi et al. Future Medicinal Chemistry
- Clinical Trials for Disease-Modifying Therapies in Alzheimer’s Disease: A Primer, Lessons Learned, and a Blueprint for the Future
- (2018) Jeffrey Cummings et al. JOURNAL OF ALZHEIMERS DISEASE
- Metabolic Dysfunction in Alzheimer’s Disease: From Basic Neurobiology to Clinical Approaches
- (2018) Julia R. Clarke et al. JOURNAL OF ALZHEIMERS DISEASE
- Microglia-Mediated Synapse Loss in Alzheimer's Disease
- (2018) Lawrence Rajendran et al. JOURNAL OF NEUROSCIENCE
- Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice
- (2018) Nupur M. Pathak et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer’s Disease
- (2018) Miren Ettcheto et al. MOLECULAR NEUROBIOLOGY
- Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases
- (2018) Monira Pervin et al. MOLECULES
- Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
- (2018) Steven E. Arnold et al. Nature Reviews Neurology
- Impaired peripheral glucose homeostasis and Alzheimer's disease
- (2018) Nadeeja Wijesekara et al. NEUROPHARMACOLOGY
- Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets
- (2018) Marcelo N.N. Vieira et al. NEUROPHARMACOLOGY
- ER Proteostasis Control of Neuronal Physiology and Synaptic Function
- (2018) Gabriela Martínez et al. TRENDS IN NEUROSCIENCES
- ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker
- (2018) Toshie Yoneyama et al. Journal of Cancer
- Green Tea Epigallocatechin-3-Gallate (EGCG) and Other Flavonoids Reduce Alzheimer's Amyloid-Induced Mitochondrial Dysfunction
- (2018) Natasa Dragicevic et al. JOURNAL OF ALZHEIMERS DISEASE
- The Pancreas-Brain Axis: Insight into Disrupted Mechanisms Associating Type 2 Diabetes and Alzheimer's Disease
- (2018) Gauri S. Desai et al. JOURNAL OF ALZHEIMERS DISEASE
- Decrease of ERK/MAPK Overactivation in Prefrontal Cortex Reverses Early Memory Deficit in a Mouse Model of Alzheimer's Disease
- (2018) Mariana Feld et al. JOURNAL OF ALZHEIMERS DISEASE
- Cocoa Extracts Reduce Oligomerization of Amyloid-β: Implications for Cognitive Improvement in Alzheimer's Disease
- (2018) Jun Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- EGCG ameliorates high-fat– and high-fructose–induced cognitive defects by regulating the IRS/AKT and ERK/CREB/BDNF signaling pathways in the CNS
- (2017) Yashi Mi et al. FASEB JOURNAL
- Diabetes and Alzheimer’s Disease: Can Tea Phytochemicals Play a Role in Prevention?
- (2017) Warnakulasuriya M.A.D.B. Fernando et al. JOURNAL OF ALZHEIMERS DISEASE
- Epigallocatechin-3-gallate ameliorates insulin resistance in hepatocytes
- (2017) Shan-Bo Ma et al. Molecular Medicine Reports
- New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9
- (2017) Elena Sánchez-López et al. Nanomedicine-Nanotechnology Biology and Medicine
- Stop Alzheimer’s before it starts
- (2017) Eric McDade et al. NATURE
- ER stress and the unfolded protein response in neurodegeneration
- (2017) Claudio Hetz et al. Nature Reviews Neurology
- (−)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer’s disease
- (2017) Yufang Guo et al. NEUROREPORT
- Obesity as a risk factor for Alzheimer's disease: weighing the evidence
- (2017) S. Alford et al. Obesity Reviews
- Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease
- (2017) Somang Kang et al. YONSEI MEDICAL JOURNAL
- On the path to 2025: understanding the Alzheimer’s disease continuum
- (2017) Paul S. Aisen et al. Alzheimers Research & Therapy
- Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer’s Therapy?
- (2017) Marcelo N. N. Vieira et al. Frontiers in Aging Neuroscience
- The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer’s disease: an overview of pre-clinical studies and translational perspectives in clinical practice
- (2017) Marco Cascella et al. Infectious Agents and Cancer
- Diabetes Mellitus and Alzheimer’s Disease: The Protection of Epigallocatechin-3-gallate in Streptozotocin Injection-Induced Models
- (2017) Jin-Jing Jia et al. Frontiers in Pharmacology
- Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe / PS1dE9 through multiple signaling pathways
- (2017) Miren Ettcheto et al. Redox Biology
- Protective role of epigallocatechin-3-gallate in health and disease: A perspective
- (2016) Animesh Chowdhury et al. BIOMEDICINE & PHARMACOTHERAPY
- Long-Term Consumption of High-Fat Diet in Rats: Effects on Microglial and Astrocytic Morphology and Neuronal Nitric Oxide Synthase Expression
- (2016) Kinga Gzielo et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Epigallocatechin gallate attenuates amyloid β-induced inflammation and neurotoxicity in EOC 13.31 microglia
- (2016) James Cheng-Chung Wei et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer’s Disease Stage in APP/PS1 Mice
- (2016) Miren Ettcheto et al. JOURNAL OF ALZHEIMERS DISEASE
- Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model
- (2016) Do-Geun Kim et al. Journal of Neuroinflammation
- Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial
- (2016) Rafael de la Torre et al. LANCET NEUROLOGY
- Neuroprotection Through Rapamycin-Induced Activation of Autophagy and PI3K/Akt1/mTOR/CREB Signaling Against Amyloid-β-Induced Oxidative Stress, Synaptic/Neurotransmission Dysfunction, and Neurodegeneration in Adult Rats
- (2016) Abhishek Kumar Singh et al. MOLECULAR NEUROBIOLOGY
- Beneficial Effects of Tea and the Green Tea Catechin Epigallocatechin-3-gallate on Obesity
- (2016) Takuji Suzuki et al. MOLECULES
- Unfolded Protein Response and PERK Kinase as a New Therapeutic Target in the Pathogenesis of Alzheimer’s Disease
- (2015) Wioletta Rozpedek et al. CURRENT MEDICINAL CHEMISTRY
- (−)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer׳s disease model mice by upregulating neprilysin expression
- (2015) Xiang Chang et al. EXPERIMENTAL CELL RESEARCH
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer's disease β-amyloid oligomerization
- (2015) Dongjie Wang et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
- (2015) Neha Atulkumar Singh et al. Nutrition Journal
- Epigallocatechin-3-gallate enhances clearance of phosphorylated tau in primary neurons
- (2015) Adrianne S. Chesser et al. NUTRITIONAL NEUROSCIENCE
- Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease
- (2014) F. G. De Felice et al. DIABETES
- Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
- (2014) M. Yarchoan et al. DIABETES
- ATF4: a Novel Potential Therapeutic Target for Alzheimer’s Disease
- (2014) Na Wei et al. MOLECULAR NEUROBIOLOGY
- Insulin resistance in Alzheimer's disease
- (2014) Kelly T. Dineley et al. NEUROBIOLOGY OF DISEASE
- Alzheimer’s as a metabolic disease
- (2013) Lloyd A. Demetrius et al. BIOGERONTOLOGY
- Alzheimer’s disease and insulin resistance: translating basic science into clinical applications
- (2013) Fernanda G. De Felice JOURNAL OF CLINICAL INVESTIGATION
- (−)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus
- (2013) Ning Jia et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- (−)-Epigallocatechin-3-Gallate Ameliorates Learning and Memory Deficits by Adjusting the Balance of TrkA/p75NTR Signaling in APP/PS1 Transgenic Mice
- (2013) Mingyan Liu et al. MOLECULAR NEUROBIOLOGY
- Neurovascular coupling, cerebral white matter integrity, and response to cocoa in older people
- (2013) F. A. Sorond et al. NEUROLOGY
- Glucose Levels and Risk of Dementia
- (2013) Paul K. Crane et al. NEW ENGLAND JOURNAL OF MEDICINE
- The case for soluble Aβ oligomers as a drug target in Alzheimer's disease
- (2013) Franz Hefti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Benefits in Cognitive Function, Blood Pressure, and Insulin Resistance Through Cocoa Flavanol Consumption in Elderly Subjects With Mild Cognitive Impairment
- (2012) Giovambattista Desideri et al. HYPERTENSION
- Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties
- (2012) Young-Jung Lee et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice
- (2012) Henrik Ortsäter et al. Nutrition & Metabolism
- The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor
- (2011) Xiao-Rui Cheng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes
- (2011) Ying Liu et al. JOURNAL OF PATHOLOGY
- Modulation of Nrf2/ARE Pathway by Food Polyphenols: A Nutritional Neuroprotective Strategy for Cognitive and Neurodegenerative Disorders
- (2011) Giovanni Scapagnini et al. MOLECULAR NEUROBIOLOGY
- Structure and permeability changes of the blood-brain barrier in APP/PS1 mice: an Alzheimer’s disease animal model
- (2011) Yulin Wang et al. Neurochemical Journal
- CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease
- (2010) A. Caccamo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ADAM10 as a Therapeutic Target for Cancer and Inflammation
- (2009) Howard Crawford et al. CURRENT PHARMACEUTICAL DESIGN
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started